Abstract
In the last decade the heat shock protein 90 (Hsp90) has emerged as a major therapeutic target and many efforts have been dedicated to the discovery of Hsp90 inhibitors as new potent anticancer agents. Here we report the identification of a novel class of Hsp90 inhibitors by means of a biophysical FAXS-NMR based screening of a library of fragments. The use of X-ray structure information combined with modeling studies enabled the fragment evolution of the initial triazoloquinazoline hit to a class of compounds with nanomolar potency and drug-like properties suited for further lead optimization.
| Original language | English |
|---|---|
| Pages (from-to) | 4135-4150 |
| Number of pages | 16 |
| Journal | Bioorganic & Medicinal Chemistry |
| Volume | 22 |
| Issue number | 15 |
| Early online date | 14 Jun 2014 |
| DOIs | |
| Publication status | Published - 1 Aug 2014 |
Fingerprint
Dive into the research topics of 'Fragment-based hit discovery and structure-based optimization of aminotriazoloquinazolines as novel Hsp90 inhibitors'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver